Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer
Titel:
Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer
Auteur:
Carneiro, Benedito A. Ramanathan, Ramesh K. Fakih, Marwan G. Krishnamurthi, Smitha S. Lembersky, Barry C. Stoller, Ronald G. Lancaster, Stewart L. Pinkerton, Richard A. Crandall, Theodore L. Schmotzer, Amy R. Potter, Douglas M. Bahary, Nathan